Mary Theresa Coelho - Sep 9, 2021 Form 4 Insider Report for AzurRx BioPharma, Inc. (FWBI)

Role
Director
Signature
/s/ Mary Theresa Coelho
Stock symbol
FWBI
Transactions as of
Sep 9, 2021
Transactions value $
$0
Form type
4
Date filed
9/13/2021, 08:08 PM
Previous filing
Aug 17, 2021
Next filing
Jan 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Award $0 +10.3K $0.00 10.3K Sep 9, 2021 Common stock, par value $0.0001 per share 10.3K $0.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of derivative securities reported has not been adjusted to reflect the 10-for-1 reverse stock split of AzurRx BioPharma, Inc. common stock that occurred on September 13, 2021.
F2 The stock option vests on December 31, 2021.